İçeriğe geç

Onkoloji

Ameliyat Sırasında Otolog Kan Yönetimi

Kan Hücresi Kurtarma

Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. (opens new window)

Akbulut S, Kayaalp C, Yilmaz M, Ince V, Ozgor D, Karabulut K, Eris C, Toprak HI, Aydin C, Yilmaz S.

Kaynak‎: World J Gastroenterol 2013;19(10):1625-31.

İndeks‎: PubMed 23538988

DOI‎: 10.3748/wjg.v19.i10.1625

https://www.ncbi.nlm.nih.gov/pubmed/23538988 (opens new window)

Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? (opens new window)

Araujo RL, Pantanali CA, Haddad L, Rocha Filho JA, D'Albuquerque LA, Andraus W.

Kaynak‎: World J Gastrointest Surg 2016;8(2):161-8.

İndeks‎: PubMed 26981190

DOI‎: 10.4240/wjgs.v8.i2.161

https://www.ncbi.nlm.nih.gov/pubmed/26981190 (opens new window)

Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. (opens new window)

Bower MR, Ellis SF, Scoggins CR, McMasters KM, Martin RC.

Kaynak‎: Ann Surg Oncol 2011;18(1):166-73.

İndeks‎: PubMed 21222043

DOI‎: 10.1245/s10434-010-1228-4

https://www.ncbi.nlm.nih.gov/pubmed/21222043 (opens new window)

Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. (opens new window)

Gorin MA, Eldefrawy A, Manoharan M, Soloway MS.

Kaynak‎: World J Urol 2012;30(3):379-83.

İndeks‎: PubMed 21847657

DOI‎: 10.1007/s00345-011-0746-4

https://www.ncbi.nlm.nih.gov/pubmed/21847657 (opens new window)

Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. (opens new window)

Han S, Kim G, Ko JS, Sinn DH, Yang JD, Joh JW, Lee SK, Gwak MS.

Kaynak‎: Ann Surg 2016;264(2):339-43.

İndeks‎: PubMed 26501715

DOI‎: 10.1097/SLA.0000000000001486

https://www.ncbi.nlm.nih.gov/pubmed/26501715 (opens new window)

Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. (opens new window)

Kumar N, Chen Y, Zaw AS, Nayak D, Ahmed Q, Soong R, Wong HK.

Kaynak‎: Lancet Oncol 2014;15(1):e33-41.

İndeks‎: PubMed 24384492

DOI‎: 10.1016/S1470-2045(13)70245-6

https://www.ncbi.nlm.nih.gov/pubmed/24384492 (opens new window)

Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture? (opens new window)

Kumar N, Zaw AS, Kantharajanna SB, Khoo BL, Lim CT, Thiery JP

Kaynak‎: Transfus Med 2017;27 Suppl 5:327-34.

İndeks‎: PubMed 28833768

DOI‎: 10.1111/tme.12453

https://www.ncbi.nlm.nih.gov/pubmed/28833768 (opens new window)

The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. (opens new window)

Mirhashemi R, Averette HE, Deepika K, Estape R, Angioli R, Martin J, Rodriguez M, Penalver MA.

Kaynak‎: Am J Obstet Gynecol 1999;181(6):1310-5.

İndeks‎: PubMed 10601905

https://www.ncbi.nlm.nih.gov/pubmed/10601905 (opens new window)

Intraoperative cell salvage during radical cystectomy does not affect long-term survival. (opens new window)

Nieder AM, Manoharan M, Yang Y, Soloway MS.

Kaynak‎: Urology 2007;69(5):881-4.

İndeks‎: PubMed 17482926

DOI‎: 10.1016/j.urology.2007.01.060

https://www.ncbi.nlm.nih.gov/pubmed/17482926 (opens new window)

Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. (opens new window)

Raval JS, Nelson JB, Woldemichael E, Triulzi DJ.

Kaynak‎: Transfusion 2012;52(12):2590-3.

İndeks‎: PubMed 22612661

DOI‎: 10.1111/j.1537-2995.2012.03682.x

https://www.ncbi.nlm.nih.gov/pubmed/22612661 (opens new window)

Should intraoperative cell-salvaged blood be used in patients with suspected or known malignancy? (opens new window)

Trudeau JD, Waters T, Chipperfield K.

Kaynak‎: Can J Anaesth 2012;59(11):1058-70.

İndeks‎: PubMed 22996966

DOI‎: 10.1007/s12630-012-9781-x

https://www.ncbi.nlm.nih.gov/pubmed/22996966 (opens new window)

Blood salvage and cancer surgery: a meta-analysis of available studies. (opens new window)

Waters JH, Yazer M, Chen YF, Kloke J.

Kaynak‎: Transfusion 2012;52(10):2167-73.

İndeks‎: PubMed 22321196

DOI‎: 10.1111/j.1537-2995.2011.03555.x

https://www.ncbi.nlm.nih.gov/pubmed/22321196 (opens new window)

Akut Normovolemik Hemodilüsyon

Cerebral effect of acute normovolemic hemodilution during brain tumor resection. (opens new window)

Daif AA, Hassan YM, Ghareeb NA, Othman MM, Mohamed SA.

Kaynak‎: J Neurosurg Anesthesiol 2012;24(1):19-24.

İndeks‎: PubMed 21904221

DOI‎: 10.1097/ANA.0b013e31822f0346

https://www.ncbi.nlm.nih.gov/pubmed/21904221 (opens new window)

Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery. (opens new window)

Habler O, Schwenzer K, Zimmer K, Prager M, König U, Oppenrieder K, Pape A, Steinkraus E, Reither A, Buchrot A, Zwissler B.

Kaynak‎: Int J Oral Maxillofac Surg 2004;33(5):467-75.

İndeks‎: PubMed 15183411

DOI‎: 10.1016/j.ijom.2003.10.007

https://www.ncbi.nlm.nih.gov/pubmed/15183411 (opens new window)

A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. (opens new window)

Jarnagin WR, Gonen M, Maithel SK, Fong Y, D'Angelica MI, Dematteo RP, Grant F, Wuest D, Kundu K, Blumgart LH, Fischer M.

Kaynak‎: Ann Surg 2008;248(3):360-9.

İndeks‎: PubMed 18791356

DOI‎: 10.1097/SLA.0b013e318184db08

https://www.ncbi.nlm.nih.gov/pubmed/18791356 (opens new window)